Bulk Inquiry
U 99194 maleate
Axon 1069
- Parent CAS: 82668-33-5
Purity:
99%
- Soluble in water
- MF: C17H27NO2.C4H4O4
- MW: 393.47
Description
U 99194 maleate is a selective and potent dopamine D3 receptor antagonist with approximately 30-fold preference for D3 over D2 receptors. It is a useful antagonist tool for distinguishing D3-mediated responses from D2 signaling.
D3 receptors are involved in mesolimbic dopamine signaling and reward-related neurobiology. U 99194 maleate enables pharmacological blockade of D3 receptors in receptor binding, functional and behavioral pathway studies.
Key Features
- Selective dopamine D3 receptor antagonist
- Approximately 30-fold preference for D3 versus D2 receptors
- Useful for D3 versus D2 selectivity experiments
- Enables pharmacological blockade of dopamine D3 receptor signaling
Applications
- D3 receptor pharmacology
- Dopamine receptor subtype discrimination
- Reward pathway and neuropsychiatric research
- GPCR antagonist assay development
More Information
| Parent CAS No. | 82668-33-5 |
|---|---|
| Chemical Name | (5,6-Dimethoxy-indan-2-yl)-dipropyl-amine maleate |
| SMILES | C1(OC)C=C2CC(N(CCC)CCC)CC2=CC=1OC.C(/C(=O)O)=C/C(=O)O |
| MFCD | MFCD01529985 |
| InChi | InChI=1S/C17H27NO2.C4H4O4/c1-5-7-18(8-6-2)15-9-13-11-16(19-3)17(20-4)12-14(13)10-15;5-3(6)1-2-4(7)8/h11-12,15H,5-10H2,1-4H3;1-2H,(H,5,6)(H,7,8)/b;2-1- |
| InChiKey | FSIQDESGRQTFNN-BTJKTKAUSA-N |
| CID | 11957713 |
| Short Description | D3 antagonist |
U 99194 maleate
selective dopamine D3 receptor antagonist
U99194
DRD3
DRD2
dopamine D3 receptor
D3
Antagonist
GPCR signaling
dopamine signaling
D3 receptor pharmacology
Dopamine receptor subtype discrimination
Reward pathway and neuropsychiatric research
GPCR antagonist assay development
behavioral neuroscience
addiction research
GPCR pharmacology
receptor selectivity
signal transduction
GPCR
CAS 82668-33-5
CAS 234757-41-6
Axon Medchem
Axon 1069
Supplier
Vendor
References
- T Kling-Petersen et al. Effects on locomotor activity after local application of D3 preferring compounds in discrete areas of the rat brain. J. Neural Transm. 1995, 102, 209-220.
- V Audinot et al. A comparative in vitro and in vivo pharmacological characterization of the novel dopamine D3 receptor antagonists (+)-S 14297, nafadotride, GR 103,691 and U 99194. J. Pharmacol. Exp. Ther. 1998, 287, 187-197.
Related Products
Other Categories
Get a Quote for
Loading...


